Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fotini Soliotis"'
Autor:
Fotini Soliotis, Lucy Parker
Publikováno v:
Rheumatology Advances in Practice
Introduction The link between ovarian malignancy and paraneoplastic dermatomyositis is well established. Association with underlying benign ovarian pathology is much less certain, with only scarce case report evidence available. This represents the f
Publikováno v:
Rheumatology Advances in Practice
Introduction Paraneoplastic dermatomyositis is a well-recognised clinical entity, and should prompt investigation for an underlying malignancy. Immunosuppressive treatment can be effective in control of both skin and muscle disease. The effect of che
Autor:
Fotini Soliotis, Lucy Parker
Publikováno v:
Rheumatology Advances in Practice
Introduction Head drop is an unusual clinical manifestation of myositis or neuromuscular weakness, and typically requires extensive investigation to identify the underlying pathology. Case report data are limited on this topic. Case description A 72-
Autor:
Fotini, Soliotis, Clio P, Mavragani, Sotiris C, Plastiras, Dimitra, Rontogianni, Fotini N, Skopouli, Haralampos M, Moutsopoulos
Publikováno v:
Clinical and experimental rheumatology. 32(5)
Given that the clinical features of several IgG4-related diseases (IgG4-RD) can mimic those of autoimmune disorders, the aim of this study was to find possible distinguishing characteristics that would help us identify such cases from the pool of pat
Publikováno v:
International Journal of Cardiology. 59:206-208
Percutaneous transbrachial insertion of a metallic coil into the first intercostal branch of the left internal mammary artery resulted in resolution of severe angina in a 60-year-old man who had coronary artery bypass surgery 14 years previously. The
Publikováno v:
Journal of the Royal Society of Medicine. 98:271-272
In immune disorders characterized by specific autoantibody production, conventional immunosuppressive therapy can be unsatisfactory. When the illness is life threatening, B-cell depletion with a monoclonal antibody offers an additional strategy.